Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene
Publication date: Available online 4 June 2021Source: Stem Cell ResearchAuthor(s): Alexandra V. Panova, Kristina S. Kulikova, Natalia V. Klementieva, Ivan D. Krylov, Irina O. Shezhko, Anatoly N. Tiulpakov, Sergey L. Kiselev
Source: Stem Cell Research - Category: Stem Cells Source Type: research
More News: Genetics | Hyperparathyroidism | Perinatology & Neonatology | Stem Cell Therapy | Stem Cells